New functional index can predict stroke survivors'
likelihood of achieving a modified level of functional
recovery
A newly developed index, based on certain characteristics of stroke survivors when they enter a
rehabilitation facility, can predict which patients are more likely to achieve a modified level of
functional independence. In other words, the index can predict which stroke patients are more apt
to leave the rehabilitation facility, be able to eat, groom, and dress the upper body by themselves,
manage bowel and bladder functions without accidents, transfer between bed and chair without
physical assistance, and either propel a wheelchair or walk (with or without help).
Based on the index, the likelihood of achieving this stage of functioning was dramatically lower
for patients who were older; unemployed; had longer times since stroke onset; had lower scores
on daily living activities, mobility, and cognitive subscales; or were admitted from the
community
rather than from an acute hospital service. About 95 percent of persons who achieved modified
functional independence, as defined above, were discharged home from rehabilitation facilities,
compared with only 67 percent of those who did not achieve it, according to a study supported in
part by the Agency for Health Care Policy and Research (HS07595).
Knowing a patients prognosis at the beginning of rehabilitation can help family caregivers plan
for the type of care that will be needed when the patient is sent home, explains Margaret G.
Stineman, M.D., of the University of Pennsylvania. Dr. Stineman and her colleagues constructed
the Stroke RAM Index based on the records of 3,760 patients, who were discharged from 96
rehabilitation facilities in 31 States during 1990. The stage of modified functional independence
predicted by the index was achieved by only 26 percent of patients functioning below this stage
when they entered rehabilitation. The researchers point out the need for more tailored programs
of treatment and community support services to assist these patients.
Details are in "A prediction model for functional recovery in stroke," by Dr. Stineman, Greg
Maislin, M.S., M.A., Roger C. Fiedler, Ph.D., and Carl V. Granger, M.D., in the March 1997
issue of Stroke 28(3), pp. 550-556.
Racial differences persist in self-perceived health
among elders who live alone
About 30 percent of elderly blacks and whites live alone. It has been thought that elderly blacks
may be at higher risk of poor health than white elderly persons because of social and economic
disadvantages. However, a recent study shows that older blacks who live alone are not at any
higher risk of poor health than older whites who live alone, even though they perceive their
health
as poorer than their white counterparts.
It may be that blacks ascribe a different meaning than whites to the same level of functional
capacity. Or it may be that some black elders, as a result of past difficulties in acquiring the
health
services they need, may be more pessimistic about their abilities to cope with declining health.
This is important, since research has repeatedly linked perception of poor health with a higher
rate
of health problems and death, explains Chuck W. Peek, Ph.D., of the University of Florida, the
study's lead investigator. His study, supported in part by the Agency for Health Care Policy and
Research (NRSA Fellowship HS00086), was based on a sample of 1,200 survey respondents,
who were selected in 1990 from among community-dwelling residents 65 years of age and older
living in one of four counties in north Florida.
Black and white elders living alone did not differ significantly in number of chronic conditions,
overall health status, and ability to perform daily living tasks such as eating and dressing.
However, black elders were significantly more apt to report difficulty carrying out instrumental
activities of daily living, such as shopping for groceries or doing light housework, than white
elders living alone. These differences were accounted for in some but not all cases by other
factors
known to affect health, such as being female, older, and poor.
See "Race differences in the health of elders who live alone," by Raymond T. Coward, M.S.W.,
Ph.D., Dr. Peek, John C. Henretta, Ph.D., and others, in the May 1997 Journal of Aging and
Health 9(2), pp. 147-170.
Return to Contents
Special Populations
Community-based prevention programs can positively
affect some risky behaviors among disadvantaged youths
A recent study, supported in part by the Agency for Health Care Policy and Research (HS07392)
found that disadvantaged black youths who participated in a community-based
risk-behavior-reduction program were more apt to postpone initiation of specific risky behaviors,
such as sexual intercourse. They also were less likely, if they did experiment with certain risky
behaviors—for example, alcohol or tobacco use—to permanently adopt them. The
possibility of
preventing experimentation from leading to adoption is an encouraging finding, according to
Bonita Stanton, M.D., of the AHCPR-funded Center for Minority Health Research at the
University of Maryland, Baltimore.
The researchers randomized 383 black youths 9 to 15 years of age to intervention and control
groups. The intervention program focused on decisionmaking about behaviors that place youths
at
risk for AIDS, as well as behaviors that can protect against AIDS and other health problems. It
consisted of eight weekly meetings conducted privately with groups of friends at the recreation
centers and a 1-day session conducted at a rural campsite, monthly booster sessions over a
6-month period to review information and skills, and annual booster sessions at 15 and 27
months.
Intervention youths who were not engaging in unprotected sexual intercourse at the beginning of
the study were more likely to continue to avoid this risky behavior than control youths. With the
exception of unprotected sexual intercourse, the cumulative incidence of each risk behavior did
not differ notably between intervention and control youths. However, the intervention did seem
to
avert the adoption (engage in a behavior for 1 year or more) of eight risky behaviors compared
with experimentation (time-limited involvement). This difference was significant for drug use
(16
percent vs. 4 percent) and was of borderline significance for cigarette smoking (25 percent vs.15
percent). However, intervention youths were not less likely than control youths to experiment
with a risky behavior.
Details are in "Evolution of risk behaviors over 2 years among a cohort of urban
African-American adolescents," by Dr. Stanton, Xiaoyi Fang, Ph.D., Xiaoming Li, Ph.D., and
others, in the April 1997 Archives of Pediatric and Adolescent Medicine 151, pp.
398-406.
Most deaths among homeless persons occur in mid-life
and are preventable
Homeless persons in the United States, who number between 500,000 and 3 million, often die in
their 40s from preventable causes. A study of homeless adults in Boston found that the leading
cause of death among homeless persons there depended on age. Homicide was the leading cause
of death among men 18 to 44 years of age, followed by traumatic injury and poisoning (including
alcohol- and drug-related deaths). AIDS was the leading cause of death in homeless men and
women 25 to 44 years of age. Heart disease and cancer accounted for the most deaths in persons
45 to 64 years of age, with an incidence three times higher than that of the general population,
according to the study which was supported by the Agency for Health Care Policy and Research
(NRSA training grant HS00020).
Efforts to reduce the mortality rate among homeless persons should focus on these causes,
concludes Stephen W. Hwang, M.D., M.P.H., formerly of the Harvard School of Public Health
and now with St. Michael's Hospital in Toronto. Dr. Hwang and his colleagues determined the
causes of death for 17,292 adults seen by the Boston Health Care for the Homeless Program from
1988 to 1993 by comparing the program's patient database with the Massachusetts death registry
during the same years.
The average age at death was 47 years. Surprisingly, conditions generally associated with
homelessness—cold exposure and tuberculosis—were not common, but pneumonia
and influenza
were frequent causes of death, even in younger age groups. The AIDS epidemic had an enormous
effect on homeless individuals, with AIDS or HIV affecting one-fourth of the homeless
population.
Homeless persons may be at increased risk for pneumonia and influenza because of a high
prevalence of alcoholism, smoking, HIV infection, and chronic disease. The high risk of death
from homicide and accidental injury is a predictable result of poverty, substance abuse, and
living
on the streets. Finally, the increased number of deaths during the first week of each month
coincides with the arrival of disability checks, which often leads to a flurry of substance abuse,
injuries, and deaths.
The authors recommend consideration of a campaign to vaccinate all homeless persons against
pneumonia and influenza, as well as improved alcohol and drug treatment programs for homeless
persons.
Details are in "Causes of death in homeless adults in Boston," by Dr. Hwang, E. John Orav,
Ph.D., James J. O'Connell, M.D., and others, in the April 15, 1997 Annals of Internal
Medicine 126(8), pp. 625-628.
Return to Contents
Primary Care Research
Many new challenges confront primary care
researchers
Clinical studies that ignore the context of daily medical practice are likely, at best, to be of
questionable interest or use to medical directors and other policymakers within health care plans.
At worst, the findings of such studies may be misleading. Most clinical studies in primary care
will
need to include consideration of the organization, planning, financing, and administration of
health
services, as well as their outcomes.
Enthusiasm for outcomes research—especially studies that identify the most effective
methods for
preventing, diagnosing, treating, and managing common health conditions—will continue.
However, there is an even stronger interest in studies that will produce results which are directly
applicable to real-world settings. The costs as well as the effectiveness of primary care practices
will become increasingly important outcome measures, according to a recent commentary
authored by David Lanier, M.D., of the Agency for Health Care Research's Center for Primary
Care Research, and Carolyn Clancy, M.D., Acting Director of that Center and Director of
AHCPR's Center for Outcomes and Effectiveness Research.
The national trend toward quality measurement in health care will add significantly to the
research
agenda in primary care. Studies are needed to inform strategies for assessing and improving the
quality of primary care delivery in a fair and accurate manner. Future studies also should place
increased emphasis on patient preferences and involvement in the decisionmaking process in
order
to meet market-driven concerns among managed care organizations (MCOs) about consumer
satisfaction and the explosion of health-related information available to both providers and
patients through the media and over the Internet.
Health care in the United States is changing rapidly, making it more important than ever to link
researchers and practitioners. To do this, primary care research will need to involve multiple
practices or clinical sites, according to Drs. Lanier and Clancy. They suggest the establishment of
various types of practice laboratories or centers of excellence that would operate in primary care
settings across the country. Such labs might involve community practices, MCOs, and academic
medical centers. The challenge will be to forge sustainable partnerships and identify sufficient
resources to guarantee their success. The researchers encourage MCOs to engage at least in the
development of primary care research infrastructures, if not in the direct financial support of
research projects.
Details are in "Primary care research: Current challenges, future needs," by Drs. Lanier and
Clancy, in the May 1997 issue of the Journal of Family Practice 44(5), pp. 434-438.
Reprints
(AHCPR Publication No. 97-R080) are available from the AHCPR Publications Clearinghouse.
Return to Contents
AHCPR News and Notes
Quality Commission's first priority is a "Consumers'
Bill of Rights"
President Clinton issued an Executive Order in September 1996 establishing the National
Advisory Commission on Consumer Protection and Quality in the Health Care Industry. As set
forth in the Executive Order, the Commission's role is "to advise the President on changes
occurring in the health care system and recommend measures as may be necessary to promote
and
assure health care quality and value, and protect consumers and workers in the health care
system." The Commission is making progress toward its mission; a final report, including the
Commission's recommendations, is due to the President by March 30, 1998.
As its first task, the Commission is developing a "Consumers' Bill of Rights" in health care,
including recommendations for enforcing the rights at the Federal, State, and local levels. The
Consumers' Bill of Rights is due to the President in the fall. To meet this fast-approaching
deadline, the Commission's Subcommittee on Consumers' Rights, Protections, and
Responsibilities met in Washington, DC, in mid-August to continue its work on the Bill of
Rights.
The 32-member Commission is co-chaired by Secretary of Health and Human Services, Donna E.
Shalala, and the Secretary of Labor, Alexis M. Herman. Commission members, appointed March
26, 1997, represent a broad spectrum of health care expertise drawn from the private sector,
including consumer advocates, institutional providers, health care workers, State and local
government officials, and health care purchasers. As Senior Advisor on Quality to Secretary
Shalala, John M. Eisenberg, M.D., Administrator of the Agency for Health Care Policy and
Research, coordinates HHS's support for the Commission. AHCPR is staffing a liaison office to
serve as a link between HHS and the Commission.
The Commission's four subcommittees are:
- Subcommittee on Consumers' Rights, Protections, and Responsibilities.
- Subcommittee on Performance Measurement and Quality Oversight.
- Subcommittee on Quality Improvement Environment.
- Subcommittee on Roles and Responsibilities of Public and Private Purchasers and Quality
Oversight Organizations.
The Subcommittees meet on the first day of the Commission's 2-day meetings, which are held
each month. During its first three meetings, the Commission heard testimony from numerous
witnesses representing a wide array of disciplines within the health care industry, as well as
witnesses from various government agencies. All meetings of the Commission and its
Subcommittees are open to the public.
AHCPR seeks applicants for two senior-level positions
The Agency for Health Care Policy and Research is currently recruiting for the senior-level
positions of Director, Center for Primary Care Research (CPCR), and Director, Center for
Quality Measurement and Improvement (CQMI). The Director, CPCR, is a Senior Executive
Service position, and the Director, CQMI, is a Senior Biomedical Research Service position.
Both
positions offer exciting and challenging opportunities for the right individual.
The Director, CPCR, directs and supports a program of extramural and intramural health services
research on primary care, including evaluations of the quality, costs, and effectiveness of health
care; rural health care services and systems; and special populations. Applicants must have an
M.D., or equivalent degree with board certification or eligibility in a primary care speciality
such
as general internal medicine, family practice, or pediatrics. AHCPR is seeking applicants with a
comprehensive understanding of the current issues in primary care research and major public
policy initiatives affecting primary care. The salary range for this position is from $103,897 to
$123,100 per year. Applicants should make reference to vacancy announcement AHCPR-97-31.
The Director, CQMI, directs a national program of extramural and intramural health services
research to evaluate the quality of health care, assess consumer perceptions of health care
services
and systems, and develop and test measures, methods, and tools for evaluating and improving the
quality of care. The Director, CQMI, serves as the principal advisor to AHCPR's Administrator
and other senior officials on critical issues related to quality measurement and improvement and
coordinates the Agency's efforts in support of HHS's initiative to improve health care quality.
Candidates must have a doctoral-level degree in biomedicine or a related field and have
experience in directing, conducting, or evaluating scientific research programs that deal with the
measurement and improvement of the quality of health care procedures and clinical practices.
The
salary range for this position is from $79,935 to $133,600 per year. Applicants should refer to
vacancy announcement AHCPR-97-32.
Copies of the full text vacancy announcements and further information on qualification
requirements and application procedures are available online. AHCPR is an equal opportunity employer.
Return to Contents
Research Briefs
Harris, R.A., and Nease, Jr., R.F. (1997). "The importance of patient
preferences for
comorbidities in cost-effectiveness analysis." (AHCPR grants HS08362 and HS07373).
Journal of Health Economics 16, pp. 113-119.
When evaluating the cost-effectiveness of various treatments for a given (index) medical
condition, many analyses ignore the patient's other coexisting conditions. For instance, one
cost-effectiveness analysis may only assess health with the index condition on a scale from
health
in the absence of the condition to death. A second analysis may only assess health with the index
condition on a scale from ideal health to death. The latter studies assume that alleviating a health
condition, such as angina, will bring an individual to ideal health, even though the individual
may
be beset with other conditions that diminish quality of life, such as depression and congestive
heart failure. Also, the sicker the patients are who are being studied, the greater the bias
introduced by the omission of coexisting conditions in the cost-effectiveness analysis. With
either
scenario, failure to account for coexisting conditions leads to an overestimate of the efficiency
(and underestimate of the cost-effectiveness ratio) of the treatments being considered.
McClellan, M., and Newhouse, J.P. (1997). "The marginal
cost-effectiveness of medical
technology: A panel instrumental-variables approach." (AHCPR grants HS06341 and
HS07638). Journal of Econometrics 77, pp. 39-64.
Cardiac catheterization (a diagnostic procedure that images blood flow to the heart muscle) and
possible subsequent revascularization (angioplasty or bypass surgery) to restore and improve
blood flow to the heart have been associated with essentially all of the growth over the past
decade in hospital costs for treating elderly heart attack patients. The goal of this study was to
develop evidence on the marginal cost and marginal outcome effects of intensive cardiac
procedures. The researchers used data on the treatment of heart attacks in the U.S. elderly
population from 1987 to 1990 to estimate models of the incremental effects of intensive
technologies. They used "difference-in-differences" estimation techniques with a very large
number of observations and group effects to account for unobserved patient heterogeneity
(patients who actually received different treatments probably differed substantially in unobserved
dimensions). Their analysis suggested that differential trends in patient composition across
hospital types were unlikely to lead to substantial bias in their estimates, that using different
kinds
of hospitals as controls in the estimation procedure did not substantially affect results, and that
hospital adoption decisions tended to be correlated with adverse shocks in ways that led to a
downward bias in cost-effectiveness estimates. The most conservative cost-effectiveness
estimate
for the diffusion of invasive cardiac technologies is at least $40,000 per patient surviving to 1
year in 1987 dollars.
McDonald, C.J. (1997, May/June). "The barriers to electronic medical
record systems and
how to overcome them." (AHCPR grants HS07719 and HS08750). Journal of the American
Medical Informatics Association 4(3), pp. 213-221.
Institutions all want electronic medical record (EMR) systems. They want them to solve their
record movement problems; to improve the quality and coherence of the care process; and to
automate guidelines and care pathways to assist clinical research, outcomes management, and
process improvement. EMRs are very difficult to construct because the existing electronic data
sources—for example, laboratory systems, pharmacy systems, and physician dictation
systems—reside on many isolated islands with differing structures, differing levels of
granularity, and
different code systems. In this editorial, the author points out that to accelerate EMR deployment
requires a focus on the interfaces instead of the EMR system. He also notes that interface
solutions already exist in the form of standards (IP, HL7/ASTM, DICOM, LOINC, SNOMED,
and others) developed by the medical informatics community. The existing solutions just need to
be accepted. Additional research is needed to solve one remaining problem, which is the efficient
capture of physician information in coded form.
Smith, A.R., Gerber, R.L., Hughes, D.B., and others (1997, April).
"Assessment of physics
quality assurance in United States radiotherapy facilities and comparison with American
College of Radiology standard for radiation oncology physics for external beam therapy."
Seminars in Radiation Oncology 7(2), pp. 157-162.
An abundance of complex technology has recently been introduced into radiation therapy,
ranging
from computer control of accelerators and electronic portal imaging to conformal radiation
therapy and computed tomography-simulation. These researchers assessed the quality assurance
(QA) programs of radiation therapy physics at 73 sites randomly selected from the 1,321 U.S.
radiation therapy facilities. They compared the results with the Patterns of Care Study
(PCS) Consensus Guidelines for Treatment Planning and the American College of Radiology
Standard for Radiation Oncology Physics for External Beam Therapy. They estimated national
averages for facilities having QA programs as follows: for treatment planning systems (44
percent), simulators (79 percent), accelerators (94 percent), film processors (62 percent), and
blocking systems (55 percent). Only 63 percent of facilities obtained an independent check of
their
accelerator calibrations from a source outside the facility; 26 percent of facilities surveyed did not
have in vivo dosimetry capability. Based on deficiencies identified by this study and
implementation of new technologies in radiation therapy, the researchers recommend a
comprehensive national physics QA study.
Zucker, D.R., Schmid, C.H., McIntosh, M.W., and others (1997).
"Combining single
patient (N-of-1) trials to estimate population treatment effects and to evaluate individual
patient responses to treatment." (AHCPR grants T32 HS00060, HS08532, and HS07782).
Journal of Clinical Epidemiology 50(4), pp. 401-410.
When treating individual patients, physicians may face difficulties using evidence from
center-based randomized controlled trials due to limitations in the generalizability of these
studies.
To get around this, physicians often perform their own "informal" tests of treatment
effectiveness.
Single patient (N-of-1) trials provide a structure design for more rigorous assessment of medical
treatments of chronic diseases but are applied only to the index patient. In this study, the authors
present a hierarchical Bayesian random effects model to combine N-of-1 studies to obtain an
estimate of treatment effectiveness for the population and to use this population information to
aid
in the evaluation of an individual patients trial results. The model's treatment effect estimates are
adjustments between the population estimate and the individual's observed results. This
adjustment is based upon within-patient and between-patient heterogeneity. The researchers
demonstrate this patient-focused method using published data from 23 N-of-1 trial results
comparing amitriptyline and placebo for the treatment of fibromyalgia.
Return to Contents
AHCPR Publication No. 97-0070
Current as of August 1997
Internet Citation:
Research Activities newsletter. August 1997, No. 207. AHCPR Publication No. 97-0070. Agency for Health Care Policy and Research, Rockville, MD. http://www.ahrq.gov/research/aug97/